Home/Filings/4/0001213900-18-002426
4//SEC Filing

Kazma Gerald J 4

Accession 0001213900-18-002426

CIK 0001587221other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 5:38 PM ET

Size

11.9 KB

Accession

0001213900-18-002426

Insider Transaction Report

Form 4
Period: 2018-02-26
Transactions
  • Sale

    Common Stock, par value of $0.0001

    2018-02-26$11.00/sh1,500$16,500256,091 total
  • Sale

    Common Stock, par value of $0.0001

    2018-02-27$8.36/sh80,880$675,914175,211 total
  • Sale

    Common Stock, par value of $0.0001

    2018-02-27$8.26/sh5,901$48,7600 total(indirect: By LLC)
Transactions
  • Sale

    Common Stock, par value of $0.0001

    2018-02-26$11.00/sh1,500$16,500256,091 total
  • Sale

    Common Stock, par value of $0.0001

    2018-02-27$8.36/sh80,880$675,914175,211 total
  • Sale

    Common Stock, par value of $0.0001

    2018-02-27$8.26/sh5,901$48,7600 total(indirect: By LLC)
Transactions
  • Sale

    Common Stock, par value of $0.0001

    2018-02-26$11.00/sh1,500$16,500256,091 total
  • Sale

    Common Stock, par value of $0.0001

    2018-02-27$8.36/sh80,880$675,914175,211 total
  • Sale

    Common Stock, par value of $0.0001

    2018-02-27$8.26/sh5,901$48,7600 total(indirect: By LLC)
Footnotes (3)
  • [F1]The securities reported as directly beneficially owned by the Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed on this Form 4, each of whom is a manager of the Reporting Person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.25 to $8.61, inclusive. The Reporting Persons undertake to provide to Zosano Pharma Corp. ("Zosano"), any security holder of Zosano, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnotes (2) and (3) of this Form 4.
  • [F3]These shares were sold in multiple transactions at prices ranging from $8.20 to $8.35, inclusive.

Issuer

Zosano Pharma Corp

CIK 0001587221

Entity typeother

Related Parties

1
  • filerCIK 0001702234

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:38 PM ET
Size
11.9 KB